Electrochemical ELASA: improving early cancer detection and monitoring

Ana Díaz-Fernández*, Elena E. Ferapontova

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

5 Citationer (Scopus)

Abstract

The discovery of new molecular biomarkers of cancer during the last decades and the development of new diagnostic devices exploiting those have significantly contributed to the clinical analysis of cancer and to improve the outcomes. Among those, liquid biopsy sensors exploiting aptamers for the detection of cancer biomarkers in body fluids are useful and accurate tools for a fast and inexpensive non-invasive screening of population. The incorporation of aptamers in electrochemical sandwich biosensors using enzyme labels, a so-called ELASA, has demonstrated its utility to improve the detection schemes. In this review, we overview the existing ELASA assays for numerous cancer biomarkers as alternatives to the traditional ELISA and discuss their possibilities to reach the market, currently dominated by optical immunoassays. Graphical abstract: [Figure not available: see fulltext.]

OriginalsprogEngelsk
TidsskriftAnalytical and Bioanalytical Chemistry
Vol/bind415
Nummer18
Sider (fra-til)3831-3846
Antal sider16
ISSN1618-2642
DOI
StatusUdgivet - jul. 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Electrochemical ELASA: improving early cancer detection and monitoring'. Sammen danner de et unikt fingeraftryk.

Citationsformater